As covid-19 cases continued to soar in many parts of the world through the summer, IAM asked a group of leading law firms to assess how governments might relax IP rights in relation to a vaccine or other treatments
12 Aug
2020
As covid-19 cases continued to soar in many parts of the world through the summer, IAM asked a group of leading law firms to assess how governments might relax IP rights in relation to a vaccine or other treatments
